CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C02704 | BRD-K00954209 | BRD-K00954209 | -- | -- | -- | Details |
| C02705 | BRD-K00954272 | BRD-K00954272 | -- | -- | -- | Details |
| C02706 | BRD-K00955582 | BRD-K00955582 | -- | -- | -- | Details |
| C02707 | BRD-K00959089 | thenoyltrifluoroacetone | CES1 | Chelating agent | -- | Details |
| C02708 | BRD-K00959946 | BRD-K00959946 | -- | -- | -- | Details |
| C02709 | BRD-K00967758 | BRD-K00967758 | -- | -- | -- | Details |
| C02710 | BRD-K00970182 | BRD-K00970182 | -- | -- | -- | Details |
| C02711 | BRD-K00972013 | BRD-K00972013 | -- | -- | -- | Details |
| C02712 | BRD-K00973124 | BRD-K00973124 | -- | -- | -- | Details |
| C02713 | BRD-K00974016 | BRD-K00974016 | -- | -- | -- | Details |
| C02714 | BRD-K00976973 | BRD-K00976973 | -- | -- | -- | Details |
| C02715 | BRD-K00977230 | BRD-K00977230 | -- | -- | -- | Details |
| C02716 | BRD-K00991320 | BRD-K00991320 | -- | -- | -- | Details |
| C02717 | BRD-K00998404 | BRD-K00998404 | -- | -- | -- | Details |
| C02718 | BRD-K01006500 | BRD-K01006500 | -- | -- | -- | Details |
| C02719 | BRD-K01008530 | BRD-K01008530 | -- | -- | -- | Details |
| C02720 | BRD-K01009153 | BRD-K01009153 | -- | -- | -- | Details |
| C02721 | BRD-K01009906 | BRD-K01009906 | -- | -- | -- | Details |
| C02722 | BRD-K01011412 | BRD-K01011412 | -- | -- | -- | Details |
| C02723 | BRD-K01014769 | isoflupredone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C02724 | BRD-K01022714 | BRD-K01022714 | -- | -- | -- | Details |
| C02725 | BRD-K01023753 | BRD-K01023753 | -- | -- | -- | Details |
| C02726 | BRD-K01023961 | hydrazine-sulfate | -- | -- | -- | Details |
| C02727 | BRD-K01029106 | picolinic-acid | -- | -- | -- | Details |
| C02728 | BRD-K01030150 | BRD-K01030150 | -- | -- | -- | Details |
| C02729 | BRD-K01037390 | BRD-K01037390 | -- | -- | -- | Details |
| C02730 | BRD-K01039503 | sofalcone | CBR1 | Mucus protecting agent | -- | Details |
| C02731 | BRD-K01039605 | BRD-K01039605 | -- | -- | -- | Details |
| C02732 | BRD-K01045229 | BRD-K01045229 | -- | -- | -- | Details |
| C02733 | BRD-K01048110 | BRD-K01048110 | -- | -- | -- | Details |
| C02734 | BRD-K01048404 | BRD-K01048404 | -- | -- | -- | Details |
| C02735 | BRD-K01055635 | BRD-K01055635 | -- | -- | -- | Details |
| C02736 | BRD-K01060955 | BRD-K01060955 | -- | -- | -- | Details |
| C02737 | BRD-K01067435 | BRD-K01067435 | -- | -- | -- | Details |
| C02738 | BRD-K01070670 | BRD-K01070670 | -- | -- | -- | Details |
| C02739 | BRD-K01071579 | BRD-K01071579 | -- | -- | -- | Details |
| C02740 | BRD-K01077691 | BRD-K01077691 | -- | -- | -- | Details |
| C02741 | BRD-K01083922 | BRD-K01083922 | -- | -- | -- | Details |
| C02742 | BRD-K01089529 | BRD-K01089529 | -- | -- | -- | Details |
| C02743 | BRD-K01091374 | BRD-K01091374 | -- | -- | -- | Details |
| C02744 | BRD-K01093405 | BRD-K01093405 | -- | -- | -- | Details |
| C02745 | BRD-K01095011 | finasteride | SRD5A1; SRD5A2 | 5 alpha reductase inhibitor | -- | Details |
| C02746 | BRD-K01095342 | BRD-K01095342 | -- | -- | -- | Details |
| C02747 | BRD-K01096898 | BRD-K01096898 | -- | -- | -- | Details |
| C02748 | BRD-K01100412 | BRD-K01100412 | -- | -- | -- | Details |
| C02749 | BRD-K01103048 | BRD-K01103048 | -- | -- | -- | Details |
| C02750 | BRD-K01109406 | nitisinone | HPD | Hydroxyphenylpyruvate dioxygenase inhibitor | -- | Details |
| C02751 | BRD-K01121114 | AT-CSC-18 | -- | -- | -- | Details |
| C02752 | BRD-K01121544 | BRD-K01121544 | -- | -- | -- | Details |
| C02753 | BRD-K01121723 | BRD-K01121723 | -- | -- | -- | Details |
| C02754 | BRD-K01125214 | BRD-K01125214 | -- | -- | -- | Details |
| C02755 | BRD-K01140360 | BRD-K01140360 | -- | -- | -- | Details |
| C02756 | BRD-K01142063 | BRD-K01142063 | -- | -- | -- | Details |
| C02757 | BRD-K01146969 | BRD-K01146969 | -- | -- | -- | Details |
| C02758 | BRD-K01148617 | BRD-K01148617 | -- | -- | -- | Details |
| C02759 | BRD-K01152687 | BRD-K01152687 | -- | -- | -- | Details |
| C02760 | BRD-K01160827 | phenothiazine | -- | -- | -- | Details |
| C02761 | BRD-K01161236 | BRD-K01161236 | -- | -- | -- | Details |
| C02762 | BRD-K01162126 | BRD-K01162126 | -- | -- | -- | Details |
| C02763 | BRD-K01162658 | BRD-K01162658 | -- | -- | -- | Details |
| C02764 | BRD-K01166365 | BRD-K01166365 | -- | -- | -- | Details |
| C02765 | BRD-K01174345 | anamorelin | GHSR | Growth hormone secretagogue receptor agonist | -- | Details |
| C02766 | BRD-K01176062 | BRD-K01176062 | -- | -- | -- | Details |
| C02767 | BRD-K01182779 | BRD-K01182779 | -- | -- | 1-{2-[Cyano-(4,6-dimethyl-pyrimidin-2-yl)-amino]-acetyl}-piperidine-4-carboxylic acid amide | Details |
| C02768 | BRD-K01187795 | BRD-K01187795 | -- | -- | -- | Details |
| C02769 | BRD-K01188359 | vinblastine | TUBB | Tubulin inhibitor; Microtubule inhibitor | -- | Details |
| C02770 | BRD-K01192156 | BRD-K01192156 | -- | -- | tyrphostin-AG-112 | Details |
| C02771 | BRD-K01193369 | BRD-K01193369 | -- | -- | -- | Details |
| C02772 | BRD-K01202062 | BRD-K01202062 | -- | -- | -- | Details |
| C02773 | BRD-K01204681 | BRD-K01204681 | -- | -- | -- | Details |
| C02774 | BRD-K01208204 | BRD-K01208204 | -- | -- | -- | Details |
| C02775 | BRD-K01211710 | BRD-K01211710 | -- | -- | -- | Details |
| C02776 | BRD-K01212001 | BRD-K01212001 | -- | -- | -- | Details |
| C02777 | BRD-K01214267 | BRD-K01214267 | -- | -- | -- | Details |
| C02778 | BRD-K01221769 | BRD-K01221769 | -- | -- | -- | Details |
| C02779 | BRD-K01222176 | BRD-K01222176 | -- | -- | -- | Details |
| C02780 | BRD-K01222707 | BRD-K01222707 | -- | -- | -- | Details |
| C02781 | BRD-K01225247 | BRD-K01225247 | -- | -- | -- | Details |
| C02782 | BRD-K01225799 | BRD-K01225799 | -- | -- | -- | Details |
| C02783 | BRD-K01228321 | cisplatin | XIAP | DNA alkylating agent; DNA synthesis inhibitor | -- | Details |
| C02784 | BRD-K01228394 | BRD-K01228394 | -- | -- | -- | Details |
| C02785 | BRD-K01229043 | BRD-K01229043 | -- | -- | -- | Details |
| C02786 | BRD-K01237277 | BRD-K01237277 | -- | -- | -- | Details |
| C02787 | BRD-K01237500 | BRD-K01237500 | -- | -- | -- | Details |
| C02788 | BRD-K01240438 | BRD-K01240438 | -- | -- | -- | Details |
| C02789 | BRD-K01241136 | BRD-K01241136 | -- | -- | -- | Details |
| C02790 | BRD-K01244426 | cloxacillin | -- | -- | -- | Details |
| C02791 | BRD-K01245760 | BRD-K01245760 | -- | -- | -- | Details |
| C02792 | BRD-K01248935 | BRD-K01248935 | -- | -- | -- | Details |
| C02793 | BRD-K01250897 | BRD-K01250897 | -- | -- | -- | Details |
| C02794 | BRD-K01251033 | BRD-K01251033 | -- | -- | -- | Details |
| C02795 | BRD-K01253243 | SB-590885 | BRAF | RAF inhibitor | -- | Details |
| C02796 | BRD-K01263144 | BRD-K01263144 | -- | -- | -- | Details |
| C02797 | BRD-K01265221 | BRD-K01265221 | BCL2 | BCL inhibitor | -- | Details |
| C02798 | BRD-K01266518 | BRD-K01266518 | -- | -- | -- | Details |
| C02799 | BRD-K01275558 | BRD-K01275558 | -- | -- | -- | Details |
| C02800 | BRD-K01278504 | BRD-K01278504 | -- | -- | -- | Details |
| C02801 | BRD-K01281780 | BRD-K01281780 | -- | -- | -- | Details |
| C02802 | BRD-K01282863 | BRD-K01282863 | -- | -- | -- | Details |
| C02803 | BRD-K01283689 | BRD-K01283689 | -- | -- | -- | Details |